Literature DB >> 17073602

Electrotransfer into skeletal muscle for protein expression.

C Trollet1, C Bloquel, D Scherman, P Bigey.   

Abstract

An efficient and safe method to deliver DNA in vivo is a requirement for several purposes, such as study of gene function and gene therapy applications. Among the different non-viral delivery methods currently under investigation, in vivo DNA electrotransfer has proven to be one of the most efficient and simple. This technique is a physical method of gene delivery consisting in local application of electric pulses after DNA injection. Although this technique can be applied to almost any tissue of a living animal, including tumors, skin, liver, kidney, artery, retina, cornea or even brain, this review will focus on electrotransfer of plasmid DNA into skeletal muscle and its possible uses in gene therapy, vaccination, or functional studies. Skeletal muscle is a good target for electrotransfer of DNA as it is: a large volume easily accessible, an endocrine organ capable of expressing several local and systemic factors, and muscle fibres as post-mitotic cells have a long lifespan that allows long-term gene expression. In this review, we describe the mechanism of DNA electrotransfer, we assess toxicity and safety considerations related to this technique, and we focus on important therapeutic applications of electrotransfer demonstrated in animal models in recent years.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073602     DOI: 10.2174/156652306778520656

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  17 in total

1.  Physiological and histological changes in skeletal muscle following in vivo gene transfer by electroporation.

Authors:  Joseph A Roche; Diana L Ford-Speelman; Lisa W Ru; Allison L Densmore; Renuka Roche; Patrick W Reed; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

2.  Transfection by electroporation.

Authors:  Huntington Potter
Journal:  Curr Protoc Mol Biol       Date:  2003-05

3.  Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer.

Authors:  C Trollet; Y Pereira; A Burgain; E Litzler; M Mezrahi; J Seguin; M Manich; M R Popoff; D Scherman; P Bigey
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

4.  Intracellular tracking of single-plasmid DNA particles after delivery by electroporation.

Authors:  Christelle Rosazza; Annette Buntz; Thorsten Rieß; Dominik Wöll; Andreas Zumbusch; Marie-Pierre Rols
Journal:  Mol Ther       Date:  2013-08-14       Impact factor: 11.454

5.  Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.

Authors:  S D Reed; S Li
Journal:  Cancer Gene Ther       Date:  2011-01-14       Impact factor: 5.987

6.  Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.

Authors:  Romain Lefebvre; Claude Legrand; Estela González-Rodríguez; Linda Groom; Robert T Dirksen; Vincent Jacquemond
Journal:  J Physiol       Date:  2011-10-03       Impact factor: 5.182

Review 7.  Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applications.

Authors:  Joseph G Moloughney; Noah Weisleder
Journal:  Recent Pat Biotechnol       Date:  2012-12

8.  Targeted gene transfer into head and neck squamous cell carcinoma by nanosecond pulsed laser-induced stress waves.

Authors:  Koji Araki; Daisuke Mizokami; Nobuaki Tanaka; Hiroshi Suzuki; Shunichi Sato; Akihiro Shiotani
Journal:  Lasers Med Sci       Date:  2013-04-24       Impact factor: 3.161

9.  Spatial distribution and extent of electroporation by strong internal shock in intact structurally normal and chronically infarcted rabbit hearts.

Authors:  Seok C Kim; Amit Vasanji; Igor R Efimov; Yuanna Cheng
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-09

10.  Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapy.

Authors:  Chien-Wen Chang; Lane V Christensen; Minhyung Lee; Sung Wan Kim
Journal:  J Control Release       Date:  2007-10-24       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.